June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
GLAUCOMA PATIENT PLURIPOTENT STEM CELL-DERIVED ASTROCYTES CONTRIBUTE TO RETINAL GANGLION CELL NEURODEGENERATION
Author Affiliations & Notes
  • Cátia Gomes
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indianapolis, Indiana, United States
  • Kirstin VanderWall
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Kang-Chieh Huang
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Yanling Pan
    Indiana BioMedical Gateway Program, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Anna Allsop
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Sailee Sham Lavekar
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Clarisse Fligor
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Theodore Cummins
    Stark Neurosciences Research Institute, Indianapolis, Indiana, United States
    Department of Biology, Indiana University Purdue University at Indianapolis, Indianapolis, Indiana, United States
  • Jason S Meyer
    Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, United States
    Stark Neurosciences Research Institute, Indianapolis, Indiana, United States
  • Footnotes
    Commercial Relationships   Cátia Gomes, None; Kirstin VanderWall, None; Kang-Chieh Huang, None; Yanling Pan, None; Anna Allsop, None; Sailee Lavekar, None; Clarisse Fligor, None; Theodore Cummins, None; Jason Meyer, None
  • Footnotes
    Support  NIH R01 EY024984; NIH R21 EY028687; BrightFocus G2020369
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cátia Gomes, Kirstin VanderWall, Kang-Chieh Huang, Yanling Pan, Anna Allsop, Sailee Sham Lavekar, Clarisse Fligor, Theodore Cummins, Jason S Meyer; GLAUCOMA PATIENT PLURIPOTENT STEM CELL-DERIVED ASTROCYTES CONTRIBUTE TO RETINAL GANGLION CELL NEURODEGENERATION. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3154.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinal ganglion cell (RGC) degeneration is a primary characteristic of glaucoma, although non-cell autonomous mechanisms have been implicated in RGC dysfunction. Astrocytes associate with RGCs in the nerve fiber layer of the retina and optic nerve, where they can contribute to RGC neurodegeneration. However, the mechanisms by which astrocytes promote neurotoxicity and contribute to glaucoma remain unknown.

Methods : Human pluripotent stem cells (hPSCs) can serve as powerful tools for the in vitro study of neurodegenerative diseases, including neuron-glia interactions. Using hPSC-derived cells from a glaucoma patient with an Optineurin (OPTN) E50K mutation (linked to inherited forms of glaucoma) as well as isogenic control cells obtained by CRISPR/Cas9 gene editing, we explored how the OPTN(E50K) mutation affects RGC-astrocyte interactions leading to neurodegeneration.

Results : hPSC-derived OPTN(E50K) astrocytes exhibited a hypertrophic shape and increased branching, as well as autophagy dysfunction and altered mitochondrial dynamics. Transcriptional analysis showed upregulation of the inflammatory pathway and downregulated axonal guidance in OPTN(E50K) astrocytes, suggesting they confer neurotoxicity and/or a lack of neurosupportive roles. Therefore, the contribution of astrocytes to RGC neurodegeneration was determined through co-cultures. Importantly, compared to the effect promoted by isogenic control astrocytes, OPTN(E50K)-astrocytes induced degenerative phenotypes in RGCs, including decreased neurite length and complexity, together with increased excitability, in both OPTN(E50K) and isogenic control RGCs. Conversely, isogenic control astrocytes were capable of rescuing degenerative phenotypes observed in OPTN(E50K) RGCs. Glaucomatous astrocytes secrete reduced levels of certain growth factors, suggesting a deficit in their neurosupportive role. In accordance, the incubation of OPTN(E50K) RGCs with these factors increased neurite branching and synaptic protein expression, highlighting the role of astrocyte-derived factors in RGC support.

Conclusions : These results are the first of its kind to identify a neurotoxic phenotype in hPSC-derived astrocytes from a glaucomatous source, as well as to identify a role for astrocytes in the neurodegenerative process through non-cell autonomous mechanisms, highlighting these glial cells as novel potential therapeutic targets in glaucoma.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×